A comparison of the CAT reporter activity of a plasmid which contains the 232 bp epithelial specific enhancer alone with that of plasmids which contain additional sequences from the human papillomavirus type 16 ( HPV-16) upstream regulatory region (URR) revealed two markedly different patterns, in an analysis of six human epithelial cell lines. In HeLa, C33A and SiHa, the CAT reporter activities of all the constructs were comparable. In contrast, in CaSki, HK2bE6-E7 and HaCaT we detected very low levels of CAT reporter activity using the constructs with the additional HPV-16 URR sequences. The ability of HPV-16 E2 to transactivate a construct with 2 E2 binding sites also differed markedly and showed the same pattern. Cytokeratin staining revealed a correlation between cytokeratin 10 and 14 expression and the transcriptional differences observed. We also found alterations in the activity of one of the constructs on altering the growth conditions of the HaCaT cell line.
A comparison of the CAT reporter activity of a plasmid which contains the 232 bp epithelial specific enhancer alone with that of plasmids which contain additional sequences from the human papillomavirus type 16 ( HPV-16) upstream regulatory region (URR) revealed two markedly different patterns, in an analysis of six human epithelial cell lines. In HeLa, C33A and SiHa, the CAT reporter activities of all the constructs were comparable. In contrast, in CaSki, HK2bE6-E7 and HaCaT we detected very low levels of CAT reporter activity using the constructs with the additional HPV-16 URR sequences. The ability of HPV-16 E2 to transactivate a construct with 2 E2 binding sites also differed markedly and showed the same pattern. Cytokeratin staining revealed a correlation between cytokeratin 10 and 14 expression and the transcriptional differences observed. We also found alterations in the activity of one of the constructs on altering the growth conditions of the HaCaT cell line.
Human papillomavirus type 16 (HPV-16) genomes are present in a very large proportion of cervical cancers and the E6 and E7 oncogenes of the virus are believed to be the major transforming genes (for review see zur Hausen, 1996) . The non-coding region of HPV-16 is usually referred to as the upstream regulatory region (URR) since it modulates the activity of the p97 promoter which controls transcription of the E6 and E7 oncogenes. In situ hybridization studies on clinical infections (Durst et al., 1992 ; Stoler et al., 1989) and virion generation efforts using raft culture systems have emphasized (Dollard et al., 1992) both the epithelial specificity and the tight link between the regulation of papillomavirus transcription and the differentiation of epithelial cells. In addition, during the progression to higher grade lesions and Author for correspondence : Vinay Tergaonkar.
Fax j91 80 3343851. e-mail vinay!ncbs.tifrbng.res.in subsequent malignancy from the initial infection, it is believed that the URRs of HPV-16 and HPV-18 are upregulated, although the mechanisms are as yet poorly understood (for reviews see Souza et al., 1990 ; zur Hausen, 1996 ; HoppeSeyler & Butz, 1994) . Based on the frequently observed Fig. 1 . Map of plasmid constructs. The pLCR16-DEL and 232 bp constructs were gifts of H. Pfister (May et al., 1994) and H. U. Bernards respectively (Chong et al., 1991) . Construct pH243 was generated as described in the text. The 2 E2 (Hawley-Nelson et al., 1988) and 6 E2 binding site constructs (Sakai et al., 1996) were gifts of E. Androphy and P. M. Howley respectively. The mutant and wild-type YY1 binding site constructs were gifts of E. Seto and T. Shenk (Shi et al., 1991 Typically, six-well plates with cells at 50-60 % confluency were transfected with 1n5 µg of Qiagen column purified plasmid in a total volume of 1 ml FCS free DMEM which included 4 µl of Lipofectamine (Gibco) for HeLa, SiHa and C33A and Lipofectin (Gibco) for the other lines. This was left for 5 h prior to removal of the transfection solution disruption of the HPV-16 E2 gene in cervical tumours and the transcriptional repression of the URR detected in initial studies with HPV-16 E2, a model that emerged was that disruption of the E2 gene removes a major negative regulatory influence on the HPV-16 URR (for reviews see Ham et al, 1991 ; McBride et al., 1991) . However, more recent studies have suggested that the major function of the E2 protein is as a transactivator of the HPV-16 URR (Bouvard et al., 1994 ; Ushikai et al., 1994) , which does not provide an easy explanation for the role of the disruption of the E2 reading frame detected in most cervical tumours.
The search for an epithelial specific enhancer led to the delineation of a 400 bp segment in the URR which was subsequently reduced to a 232 bp segment (Chong et al., 1991) . Work from other groups has focused on an approximately 90 bp segment in the same region (Cripe et al., 1990) . The recent work of M. May and colleagues (May et al., 1994) , using a construct with a deletion in between the epithelial specific enhancer and the p97 promoter, has highlighted the importance of regulatory regions outside the epithelial specific enhancer modulating the overall transcriptional activity of the HPV-16 URR. However, neither the epithelial enhancer specific constructs alone or constructs with additional sequences or deletions from the URR have so far revealed significant differences within epithelial cell lines.
We are interested in using epithelial cell lines to explore the link between differentiation and regulation of the HPV-16 URR. In this study we show that constructs which have sequences in addition to the epithelial specific enhancer will modulate the transcriptional activity of the overall region in an epithelial cell line specific manner which correlates with cytokeratin expression patterns. May et al. (1994) compared the transcriptional activity of constructs which have a deletion of 107 bp (7794-7901) with constructs which contain the entire URR and reported that there is an approximately 5-fold increase in the activity of the completely and replacement with DMEM with 10 % FCS for 48 h. Cells were trypsinized and then pellets usually stored at k20 mC. Extracts were made by three rapid freeze-thaws and were used for both the reporter assay systems described. HK2bE6-E7 and HaCaT cells (when indicated) were transfected in KSFM without the supplements. Titrations and cotransfections were done with the indicated amounts of plasmids in a similar fashion. The protocols for making the extracts and the CAT assays were as per standard protocols. The acetylation products were separated by ascending thin-layer chromatography. The incubation times for the CAT assays, unless indicated otherwise, were 2-4 h for CaSki, HK2bE6-E7 and HaCaT and 30 min for all the other lines. At least two representative CAT assays were normalized using β-galactosidase activities following co-transfection with pCH110 (Pharmacia) and an ONPG assay. Percentage acetylation was determined by cutting-out the spots and quantification of 14 C-activity by liquid scintillation counting. β-Galactosidase assay reactions were performed for 30 min to 2 h for all the cells, with the exception of CaSki, HaCaT and E6-E7 cells, for which the reactions were carried out for up to 6 h. (d) pLCR16-DEL, pH243 and 232 bp CAT activities of HaCaT cells grown in two different media for 48 h prior to transfection. The HaCaT line grown in DMEM with 10 % FCS was transfected as described previously with the indicated plasmids. After transfection, either DMEM with 10 % FCS or KSFM with supplements were added to the dishes and the cells were grown for a further 48 h. (e) Transactivation of 2 E2 and 6 E2 binding site plasmids by HPV-16 E2. The figure is representative of at least two independent assays. 750 ng of the E2 binding site plasmids and an equal amount of pCMV16E2 vector expressing HPV-16 E2 were used. Transfections were done as in (a)-(d) except that an equivalent amount of salmon sperm DNA was used as dummy in reactions when no E2 encoding plasmid was added. All the transactivation reactions with 2 E2 and 6 E2 binding sites in all the cell lines were carried out for 2 h. In an effort to obtain transactivation with 2 E2 binding sites with CaSki, HaCaT and HK2bE6-E7 lines incubations were continued for up to 8 h but no significant decrease was detected. Titrations with up to 4 µg of 16 CMV E2 plasmid were performed and no detectable transactivation was observed in the lines where no transactivation of the 2 E2 binding site was seen (data not shown).
construct with the deletion in all epithelial cell lines they analysed. Their analysis in the same study suggested that the YY1 sites in the region 7794-7901 are the key to the repression of the p97 promoter. Using the same deletion construct, pLCR16-DEL (Fig. 1) , we found that there were marked differences in the CAT reporter activity of this plasmid following transfection into various human epithelial cell lines. Following transfection of the pLCR16-DEL construct into cell lines HeLa, C33A and SiHa, we were able to easily detect CAT activity. However, we were unable to easily measure CAT activity in the CaSki, HK2bE6-E7 and HaCaT cell lines (Fig.  2 a) . In comparison, in all six lines, we were easily able to detect comparable activity of the 232 bp epithelial specific enhancer construct (Chong et al., 1991) . A titration using increasing amounts of plasmid pLCR16-DEL revealed no significant increase in CAT activity (Fig. 2 b) of this construct. The activity of the 232 bp enhancer and an SV40 CAT plasmid were similar in all the lines, with transfections in CaSki shown as a representative (Fig. 2 b) . On prolonged incubation, which resulted in the activity of the 232 bp construct transfected cells entering the non-linear range, we detected around 1-2 % CAT conversion in the pLCR16-DEL construct transfected cell extracts from CaSki, HK2bE6-E7 and HaCaT (Fig. 2 a) . In Fig.  2(c) , we show that under transfection and CAT assay conditions wherein the activity of the 232 bp construct transfected HeLa, C33A and SiHa cells entered the non-linear range, the CAT conversion of the pLCR16-DEL transfected cells was around 25 %. Using CAT conversion values from activities which are in the linear range, pLCR16-DEL transfections reveal a 10-20-fold difference in the CAT activities across the two sets of cell lines (Fig. 2 a, c) . The pLCR16-DEL construct preserves the most promoter proximal region (7901-97) in addition to the epithelial enhancer region. To generate a construct which would remove the most promoter proximal region selectively, we generated plasmid pH243 ( 16 URR and subcloning it into the HindIII-XbaI site of pBLCAT2. This construct retains the epithelial specific enhancer region along with the key YY1 site in the 7794-7901 region as identified by May et al. (1994) . Transfections and titrations undertaken with pH243 under conditions identical to those for the pLCR16-DEL construct showed the same range and cell line specific patterns as observed with pLCR16-DEL transfections (Fig. 2 a-c) . The above experiments were undertaken using the HaCaT line grown in standard DMEM (Gibco) medium. On shifting this line to a special keratinocyte growth medium, KSFM (Gibco), we detect a 20-fold increase in the activity of the pH243 construct, with no significant changes in the pLCR16-DEL construct transfected cells (Fig. 2 d) . The absence of a comparable activity of the pH243 construct in the HK2bE6-E7 line grown in KSFM suggests that this phenomenon might be unique to the HaCaT cell line and reflects transcriptional changes independent of cytokeratin patterns of expression.
There are a considerable number of E2 and YY1 binding sites in the region between the 232 bp region and the p97 promoter and we explored the possibility of differences in the transactivation of E2 and YY1 binding sites. We find that the ability to transactivate a construct with 2 E2 binding sites (Fig.  1) linked to an SV40 promoter (Hawley-Nelson et al., 1988) by the HPV-16 E2 protein (Sakai et al., 1996) also falls into a similar pattern, with virtually no detectable activity in CaSki, HK2bE6-E7 and HaCaT (grown in either medium) transfected cells and easily detectable transactivation in cell lines HeLa, C33A and SiHa (Fig. 2 e) . Interestingly, the three lines CaSki, HK2bE6-E7 and HaCaT, on transfection with a 6 E2 binding site plasmid (Fig. 1) linked to a tk promoter (Sakai et al., 1996) , did not reveal any differences when compared to similar transfections undertaken with HeLa, C33A and SiHa (Fig. 2 e) . The previously reported dimerization of the E2 protein might offer an explanation for the transactivation differences in Fig.  2(e) (McBride et al., 1991) . An interesting analysis of the bovine papillomavirus type 4 URR has raised the importance of host factors modulating transcription of the URR through E2 binding sites (Jackson & Campo, 1995) . There is no direct evidence in our study for the involvement of the E2 binding sites in the observations with the pLCR16-DEL construct. Future studies with a detailed mutagenesis of the E2 binding sites, an assessment of the activation of different E2 binding motifs and the effects of different promoters will hopefully provide much firmer evidence for the involvement of the E2 binding sites in mediating the transcriptional differences of the URR constructs reported in this study.
Using a CAT ELISA based system, we have measured the activity of mutant versus wild-type YY1 (Fig. 1) binding sites (Shi et al., 1991) linked to an SV40 promoter : the ratio of mutant to wild-type activities was 1n3 in all the lines. The HaCaT line grown in different conditions also revealed the same ratio of YY1 activity using the wild-type and mutant constructs. The importance of the YY1 protein was initially investigated in interactions of this protein with the adenovirus E1A protein by T. Shenk and co-workers (Shi et al., 1991) and subsequently in the regulation of papillomavirus transcription by H. zur Hausen and co-workers (Bauknecht et al., 1995) and H. Pfister and co-workers (May et al., 1994) . Recently, H. U. Bernard and colleagues further analysed the contribution of the various YY1 sites in repression of the p97 promoter (O'Connor et al., 1996) . The absence of discernible differences in the YY1 activity across epithelial cell lines in our experiments is likely to be due to the constructs which we have used, which do not measure the role of YY1 in the natural context of the p97 promoter. We hope that an extension of this analysis along the directions of O'Connor et al. (1996) will provide a mechanistic basis for the observations with the pH243 construct.
In order to explore the possibility of a correlation between the transcriptional differences we detect and the differentiation status of these cell lines, we analysed all the cell lines with a range of anti-cytokeratin antibodies. The cytokeratin staining pattern reveals that CaSki (Choo et al., 1994) and HK2bE6-E7 express cytokeratin 14 but not cytokeratin 10 (Sedman et al., 1991) , a pattern consistent with a cell lined derived from the basal epithelial layer (Fig. 3) . The other three lines, HeLa, SiHa and C33A, express 10 but not 14, a pattern consistent with cells derived from a higher layer (Fig. 3) . The HaCaT line grown in DMEM with 10 % FCS showed cytokeratin 10 expression only in 15 % of the cells and did not express any detectable cytokeratin 14, suggesting that it was partially differentiated. Growing this line in KSFM medium induced expression of cytokeratin 14 in almost all the cells, with no detectable cytokeratin 10, a pattern more consistent with a basal cell phenotype. All the human epithelial lines stained positively with a pan cytokeratin antibody as control (Fig. 3) .
The very recent work of H. U. Bernard and colleagues suggests that during the process of transformation there is a shift in the Sp1\Sp3 ratios (Apt et al., 1996) with an upregulation of the p97 promoter. Our observations do not suggest a correlation with transformation given that CaSki, C33A, HeLa and SiHa are derived from tumours, while HaCaT is a spontaneously immortalized keratinocyte line (Boukamp et al., 1988) and HK2bE6-E7 is a retrovirus transformed line with HPV-16 E6\E7 (Sedman et al., 1991) . We are indeed surprised by the correlates we detect with cytokeratin patterns and transcriptional upregulation of the URR, considering the differing genetic backgrounds of the cell lines, absence of viral genomes in C33A and the differing number and type of HPV genomes in CaSki, HeLa and SiHa. The observations in our study and that of Apt et al. (1996) , who differentiated primary keratinocytes using methylcellulose and saw a 3n5-fold increase in transcription of their plasmid construct (which has the promoter proximal region linked to the 232 bp enhancer), would emphasize a link between transcriptional regulation and cytokeratin patterns. Work from our laboratory has recently suggested that there are no HPV-16 episomes in high grade CIN lesions (Daniel et al., 1995 (Daniel et al., , 1997 and a large proportion CGAE To be completed by author To be completed by author Fig. 3 . Cytokeratin expression in epithelial cell lines. Cytokeratin antigen detection using keratin specific antibodies (from Sigma except for anti-cytokeratin 10 from Dako) was undertaken on cell lines fixed for 10 min with 4 % paraformaldehyde in PBS. Following blocking and permeabilization steps for 1 h each at 37 mC using 0n5 % BSA in PBS and 0n2% Triton X-100, the primary antibodies at appropriate dilution were added (dilution varied from 1 in 50 to 1 in 800) and incubations carried out at 37 mC for 1 h. The secondary antibody used was a goat anti-mouse biotinylated antibody used at 1 in 500 dilution (Bangalore Genei) followed by a biotin-streptavidin-HRP conjugate (Vector Laboratories). After each incubation cells were washed three times in 1iPBS, 0n5 % BSA for 5 min. Hydrogen peroxide was added to a final concentration of 0n06 % along with diaminobenzidine (0n62 mg/ml) and the colour reaction stopped by washing with PBS after 2 min. Photography was done using a camera attached to a Leitz (Germany) microscope under bright field illumination (20i). COS, a monkey endothelial line, was included as negative control.
of high-grade CIN lesions and tumours express cytokeratin 10. It is conceivable that the findings in this study with the cytokeratin 10 positive epithelial cell lines are consistent with the upregulation of E6\7 transcripts detected in high grade CIN lesions and tumours.
